Health Care: Health Services

Bio-Reference Laboratories Inc (BRLI: NASDAQ)

$31.82 0.55 | 1.76%
12/24/14 - 01:00 PM ET
Company Income Statement
Oct 2014 Oct 2013 Oct 2012 Oct 2011
Sales 832.28M 715.35M 661.66M 558.64M
Cost of Sales 462.28M 377.22M 324.54M 276.82M
Gross Operating Profit 370.00M 338.14M 337.12M 281.82M
Selling, General, and Administrative Expenses 286.57M 236.42M 244.32M 207.05M
Research & Development n.a. 0.00 0.00 0.00
Operating Income before D & A (EBITDA) 83.42M 101.71M 92.79M 74.78M
Depreciation & Amortization n.a. 19.74M 16.66M 15.00M
Interest Income n.a. 118.00K 163.00K 163.00K
Other Income - Net -2.46M 612.00K -323.00K 6.66M
Special Income / Charges n.a. 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 80.97M 82.70M 75.97M 66.59M
Interest Expense 0.00 1.61M 1.46M 1.75M
Pre-Tax Income 80.97M 81.10M 74.52M 64.85M
Income Taxes 34.21M 35.27M 32.36M 28.49M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 46.76M 45.82M 42.16M 36.36M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 46.76M 45.82M 42.16M 36.36M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 46.76M 45.82M 42.16M 36.36M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. 45.82M 42.16M 36.36M
Preferred Dividends
Net Income Available To Common 0.00 45.82M 42.16M 36.36M
Basic EPS from Continuing Ops. 1.69 1.65 1.52 1.30
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.69 1.65 1.52 1.30
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.69 1.65 1.52 1.30
Basic Normalized Net Income/Share n.a. 1.65 1.52 1.30
EPS fr Continuing Ops. 1.68 1.65 1.51 1.29
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.68 1.65 1.51 1.29
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.68 1.65 1.51 1.29
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
n.a. 1.65 1.51 1.29
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with BRLI

Latest BRLI Headlines from TheStreet

More Financial News for BRLI

Press Releases for BRLI

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter